GSK | ISPOR (Global Market Access Fellowship)
About GSK
GSK is a global healthcare company with a special purpose: to unite science, talent and technology to get ahead of disease together. They prevent and treat disease with vaccines, specialty, and general medicines with ambition, accountability, and responsibility. Their goal is to be one of the world’s most innovative, best performing and trusted healthcare companies. GSK’s motivation is to positively impact the health of 2.5 billion people with our medicines and technologies by the end of the decade.
About ISPOR
ISPOR: The Professional Society for Health Economics and Outcomes Research is the leading global professional society for health economics and outcomes research. Its mission is to advance HEOR excellence to improve decision making for health globally, with a vision of healthcare that is accessible, effective, efficient, and affordable for all.
About Rutgers HOPE
The Rutgers University Center for Health Outcomes, Policy, and Economics partners with scientists, clinicians and stakeholders from academia, pharmaceutical, biotech, and other marketplace innovators to conduct interdisciplinary research that produces relevant, meaningful health outcomes, economic models and analyses to facilitate the adoption of cost-effective healthcare and improve patient outcomes.
Fellowship Team
Mike Spencer
Fellowship Executive Leader | GSK
Chintan Dave, PharmD, PhD
Fellowship Director | Rutgers
Soham Shukla, PharmD, MS
Fellowship Director | GSK
Laura Pizzi, PhD
Fellowship Director | ISPOR
Program and Structure
The GSK Global Market Access (GMAx) Fellowship offers PharmD graduates a unique opportunity to gain broad exposure to the strategic, scientific, and business aspects of pharmaceutical market access within a leading global biopharmaceutical company. Designed to develop future leaders, the fellowship provides hands-on experience supporting innovative medicines and vaccines across multiple therapeutic areas. Global Market Access is at the heart of developing and launching medicines, connecting country teams with global strategic functions, evidence generation, R&D, and other cross-functional partners.
Through a combination of rotational and project-based experiences, fellows will develop a deep understanding of how pricing, reimbursement, health policy, evidence generation, and healthcare system dynamics influence patient access to medicines around the world. Fellows will have opportunities to contribute across the end-to-end medicine development process, including work on early assets to understand future evidence needs, inform clinical development, and anticipate healthcare system and policy considerations, as well as work on launch-stage assets involving value proposition development and market preparation. Fellows will also gain experience across Global Market Access, Global Pricing, Health Policy & Systems Engagement, and U.S. Market Access, gaining exposure to both global strategy development and local market implementation.
The fellowship emphasizes professional growth through mentorship, cross-functional collaboration, and direct involvement in high-impact projects that shape access strategies throughout the product lifecycle. Fellows will hear access challenges directly from country teams and contribute to the development of potential solutions. They will also work with colleagues across Commercial, Medical Affairs, R&D, Evidence Generation, and regional and local Market Access teams, as well as experts in HEOR, economic modeling, pricing, and other access disciplines, developing the skills needed to navigate the evolving healthcare and payer landscape.
Potential Areas of Experience
- Global Market Access Strategy
- Global Pricing & Pricing Governance
- Health Policy & Systems Engagement
- U.S. Market Access & Reimbursement
- Payer Evidence & Value Demonstration
- Health Technology Assessment (HTA)
- Launch Readiness, Market Preparation & Access Planning
- Cross-functional Strategic Decision Making
- Early Asset Access and Evidence Strategy
- Value Proposition Development
- Country Access Challenges and Solutions
The fellow will have the opportunity to take Rutgers coursework or ISPOR short courses in relevant areas such as:
- Market Access and Reimbursement for Drugs (22:630:684)
- Pharmacoeconomic Modeling (HOPE 9509)
- Health Systems and Policy (PHCO 0501)
- Reimbursement Systems for Pharmaceuticals in Europe (ISPOR short course; dependent on availability)
-
During the first year, the Fellow will develop foundational knowledge of global market access through didactic training, applied projects, mentorship, and cross-functional collaboration. The Fellow will:
- Develop an understanding of global and U.S. market access organizations, processes, and stakeholders
- Support market access strategy, pricing, reimbursement, policy, and evidence-generation projects across early-stage and launch-stage assets
- Gain exposure to payer and HTA evidence requirements across healthcare systems and understand how these requirements may inform clinical development and access planning
- Engage with global and country teams to understand local access challenges and contribute to the development of potential solutions
- Participate in ISPOR scientific, educational, or health policy initiatives
- Strengthen technical and soft skills/competencies such as scientific and executive communication, project management, and cross-functional collaboration, and influencing skills
-
During the second year, the Fellow will build upon the first-year experience with increased independence, ownership, and leadership. The Fellow will:
- Lead or independently manage components of market access projects
- Contribute to strategic recommendations supporting early-stage product development, future evidence needs, value proposition development, launch readiness, market preparation, or lifecycle management
- Work with cross-functional experts in HEOR, economic modeling, pricing, evidence generation, policy, and regional or local market access
- Communicate evidence and strategic insights to senior leaders and cross-functional stakeholders
- Assume greater responsibility within an ISPOR scientific or health policy initiative
- Complete remaining graduate coursework or academic requirements, as applicable
- Complete and disseminate the Rutgers research project through a manuscript, conference presentation, or other scholarly product
- Support the professional development of incoming fellows and other trainees
